TIANBAO ENERGY (01671) announced its interim results, with a profit attributable to shareholders of 9.219 million yuan, a decrease of 6.77% year-on-year.
Tianbao Energy (01671) announced its interim results for the six months ended June 30, 2026, with revenue of 392 million yuan, representing a year-on-year increase of 3.3%; profit attributable to equity shareholders was 9.219 million yuan, a decrease of 6.77% year-on-year; earnings per share were 5.76 cents.
TIANBAO ENERGY (01671) announced its interim results for the six months ended June 30, 2026, reporting a revenue of 392 million yuan, an increase of 3.3% year-on-year; the profit attributable to equity shareholders was 9.219 million yuan, a decrease of 6.77% year-on-year; earnings per share were 5.76 cents.
The announcement stated that the decline in profit was mainly due to a reduction in power generation revenue because of equipment maintenance; and while the profit from Lingang Thermal Power increased, most of it was accounted for as profit attributable to non-controlling interests, which diluted the profit attributable to equity shareholders of the company.
Related Articles

HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.
HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.

RECOMMEND





